| 注册
首页|期刊导航|天津中医药|治疗高尿酸血症药物研发现状与思考

治疗高尿酸血症药物研发现状与思考

刘金畅 王涛

天津中医药2017,Vol.34Issue(5):291-294,4.
天津中医药2017,Vol.34Issue(5):291-294,4.DOI:10.11656/j.issn.1672-1519.2017.05.02

治疗高尿酸血症药物研发现状与思考

Present research situation and thinking of drug in treating hyperuricemia

刘金畅 1王涛1

作者信息

  • 1. 天津中医药大学中医药研究院,天津 300193
  • 折叠

摘要

Abstract

Hyperuricemia is a common metabolic disease in clinic with a growing tendency of morbidity. Hyperuricemia is one of the factor causes of hypertension, diabetes, cardiovascular disease and chronic renal failure, affecting life quality of patients. Generally, reducing of uric acid production and increasing of uric acid excretion are the major methods in clinic therapy. The kinds of medication are limited and not enough for clinic demand. This paper reviewed the pathogenesis mechanism research and new drug development of hyperuricemia, analyzed the characters of traditional Chinese medicines on hyperuircemia therapy, provided a thought of anti-hyperuircemia new drug research and development on the basis of clinic effective traditional Chinese medicines.

关键词

高尿酸血症/尿酸产生与排泄/作用机制/新药发现

Key words

hyperuricemia/uric acid production and excretion/mechanism/new drug discovery

分类

医药卫生

引用本文复制引用

刘金畅,王涛..治疗高尿酸血症药物研发现状与思考[J].天津中医药,2017,34(5):291-294,4.

基金项目

国家自然科学基金面上基金项目(81173524). (81173524)

天津中医药

OACSTPCD

1672-1519

访问量0
|
下载量0
段落导航相关论文